Skip to content

PreView: The Preventive Video Education in Waiting Rooms Program

PreView: The Preventive Video Education in Waiting Rooms Program

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02264782
Enrollment
508
Registered
2014-10-15
Start date
2013-07-31
Completion date
2019-03-31
Last updated
2020-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Status Unknown

Brief summary

This clinical trial studies how well PreView, preventive video education, works in increasing rates of breast, cervical and colorectal cancer screening, improving participants' stage of change with respect to age appropriate cancer screening and increasing patient-provider discussions about prostate cancer screening.

Detailed description

PRIMARY OBJECTIVES: I. To determine the extent to which PreView increases the likelihood that primary care patient participants will receive mammograms, pap tests, colon cancer tests or prostate specific antigen (PSA) testing discussions with primary care physicians compared with participants who receive usual care. II. To determine the extent that PreView increases participants' readiness to be screened for breast cancer, cervical cancer or colorectal cancer (CRC) compared with usual care. III. To determine the extent that PreView increases the likelihood that PSA testing will be discussed in primary care physician visits compared with usual care. OUTLINE: Patients are randomized into 1 of 2 groups. GROUP I: Patients complete PreView, the Video Doctor plus Provider Alert, over 45 minutes on an iPad in the waiting room before a doctor visit. GROUP II: Patients watch a video about healthy lifestyles including information about exercise and healthy eating over 45 minutes on an iPad in the waiting room before a doctor visit.

Interventions

Complete PreView

OTHERQuestionnaire Administration

Ancillary studies

Sponsors

National Cancer Institute (NCI)
CollaboratorNIH
University of California, San Francisco
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SCREENING
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
50 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* Without a history of cancer

Exclusion criteria

* With a history of cancer (for whom subsequent procedures would be surveillance and not screening) * Individuals who do not speak English or Spanish (except for the testimonials)

Design outcomes

Primary

MeasureTime frameDescription
Changing participants' readiness to be screened for breast, cervical and colorectal cancerUp to 3 hours from pre-visit to post-visit interview.To determine the extent to which PreView increases the likelihood that primary care patient participants will receive mammograms, Pap tests, colon cancer tests or PSA testing discussions with primary care physicians compared with participants who receive usual care
Increasing physician-patient discussions about PSA screening measured by chart reviewBaseline up to 14 monthsTo determine the extent that PreView increases participants' readiness to be screened for breast cancer, cervical cancer or CRC compared with usual care.
Increasing rates of breast, cervical and colorectal cancer screeningFrom Baseline up to 14 monthsTo determine the extent that PreView increases the likelihood that PSA testing will be discussed in primary care physician visits compared with usual care.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 1, 2026